138 related articles for article (PubMed ID: 16438857)
1. [Value of mixed embolus transarterial chemoembolization in the treatment of hepatocellular carcinoma].
Li CR; Jiang WH; Feng XM; Guo YJ; Shi ZH; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):557-60. PubMed ID: 16438857
[TBL] [Abstract][Full Text] [Related]
2. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
[TBL] [Abstract][Full Text] [Related]
4. Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma.
Lu CD; Qi YG; Peng SY
Chin Med J (Engl); 1994 Mar; 107(3):209-15. PubMed ID: 8088182
[TBL] [Abstract][Full Text] [Related]
5. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
Kang JW; Kim JH; Ko GY; Gwon DI; Yoon HK; Sung KB
Acta Radiol; 2012 Jun; 53(5):545-50. PubMed ID: 22547388
[TBL] [Abstract][Full Text] [Related]
7. [Transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
Xiao EH; Hu GD; Li JQ; Huang JF
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):478-82. PubMed ID: 16188145
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.
Peng BG; He Q; Li JP; Zhou F
Am J Surg; 2009 Sep; 198(3):313-8. PubMed ID: 19285298
[TBL] [Abstract][Full Text] [Related]
9. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of preoperative transcatheter arterial embolization for improved survival rates in patients with hepatocellular carcinomas (sandwich therapy using ethiodized oil, cisplatin and gelatin sponge].
Shibata T; Sasaki Y; Imaoka S; Yasuda T; Wada H; Ishikawa O; Ohigashi H; Fukuda I; Kabuto T; Hiratsuka M
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2514-9. PubMed ID: 2843115
[TBL] [Abstract][Full Text] [Related]
11. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
12. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of transcatheter arterial chemoembolization and percutaneous injection of acetic acids on primary liver cancer.
Chen HB; Huang Y; Dai DL; Zhang X; Huang ZW; Zhang QK; Wang HH; Zhang JS; Pan G
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):55-7. PubMed ID: 14969838
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization.
Zhang XB; Wang JH; Yan ZP; Qian S; Du SS; Zeng ZC
Cancer; 2009 Mar; 115(6):1245-52. PubMed ID: 19156918
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
[TBL] [Abstract][Full Text] [Related]
17. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
[TBL] [Abstract][Full Text] [Related]
18. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
[TBL] [Abstract][Full Text] [Related]
20. Benefits and problems of transarterial therapy in patients with hepatocellular carcinoma and chronic kidney disease.
Watanabe M; Shibuya A; Minamino T; Murano J; Matsunaga K; Fujii K; Ogasawara G; Irie T; Woodhams R; Koizumi W
J Vasc Interv Radiol; 2014 Dec; 25(12):1947-55; quiz 1955. PubMed ID: 25306225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
